CHANEX

USPTO USPTO 2007 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark CHANEX was filed as Word mark on 02/27/2007 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 04/08/2008. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: August 11, 2019

Trademark form Word mark
File reference 77116990
Register number 3408109
Application date February 27, 2007
Publication date January 22, 2008
Entry date April 8, 2008

Trademark owner

MEDAWAR CENTRE, ROBERT ROBINSON AVENUE
OX44GA OXFORD
GB

Trademark representatives

goods and services

5 CLINICAL MEDICAL REAGENTS FOR USE IN GENE THERAPY; PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY; THERAPEUTIC COMPOSITIONS CONTAINING LIPOSOME REAGENTS SUITABLE FOR GENE THERAPY; THERAPUETIC COMPOSITIONS CONTAINING NUCLEIC ACIDS FOR GENE THERAPY; PHARMACEUTICAL PREPARATIONS CONTAINING NUCLEIC ACID FOR USE IN THE TREATMENT OF CANCER, HIV AND AIDS-RELATED INFECTIONS AND BODILY CONDITIONS ASSOCIATED WITH IMPAIRED IMMUNOSYSTEMS, VIRAL AND BACTIERIAL DISEASES, CANCER AND CYSTIC FIBROSIS; PHARMACEUTICAL PREPARATIONS IN THE FIELD OF GENE THERAPY; PHARMACUETICAL PREPARATIONS FOR THE TREATMENT OF CYSTIC FIBROSIS
10 INSTRUMENTS AND APPARATUS FOR THE ADMINISTRATION OF GENE THERAPY, NAMELY, SYRINGES, SCALPELS, CATHETERS, TUBES FOR THE ADMINISTRATION OF GENE THERAPY PRODUCTS; SURGICAL AND MEDICAL APPARATUS AND INSTRUMENTS, NAMELY, SYRINGES, SCALPELS, CATHETERS AND TUBES FOR MEDICAL SERVICES
42 genetic engineering services and biotechnology services, namely, development and commercialization of therapeutic vaccines and gene-based therapies in respect of oncology and neurotherapy

ID: 1377116990